BioCryst
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
CEOJon P. Stonehouse
CEOJon P. Stonehouse
Employees580
Employees580
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded1986
Founded1986
Employees580
Employees580
BCRX Key Statistics
Market cap1.80B
Market cap1.80B
Price-Earnings ratio-49.25
Price-Earnings ratio-49.25
Dividend yield—
Dividend yield—
Average volume2.31M
Average volume2.31M
High today$8.62
High today$8.62
Low today$8.35
Low today$8.35
Open price$8.37
Open price$8.37
Volume2.17M
Volume2.17M
52 Week high$11.31
52 Week high$11.31
52 Week low$6.02
52 Week low$6.02
BCRX News
Simply Wall St 2d
What BioCryst Pharmaceuticals's Leadership Change and $90M Shelf Offering Mean for ShareholdersBioCryst Pharmaceuticals recently filed a US$90.2 million shelf registration to offer up to 11,000,000 shares and announced the departure of Dr. Helen Thackray,...
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own BCRX. This list is generated using Robinhood data, and it’s not a recommendation.